Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 33.89
-0.52 (-1.51%)
May 14, 2026, 3:00 PM CST
Autobio Diagnostics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,035 | 1,068 | 1,194 | 1,217 | 1,167 | 973.66 |
Depreciation & Amortization | 461.71 | 461.71 | 477.78 | 451.61 | 432.53 | 397.11 |
Other Amortization | 30.46 | 30.46 | 31.45 | 29.87 | 31.19 | 23.46 |
Loss (Gain) From Sale of Assets | -0.64 | -0.64 | 1.17 | 0.14 | 0.13 | 0.07 |
Asset Writedown & Restructuring Costs | 4.97 | 4.97 | 64.11 | 2.64 | 1.6 | 1.72 |
Loss (Gain) From Sale of Investments | -101.01 | -101.01 | -95.88 | -129.96 | -118.59 | -108.38 |
Provision & Write-off of Bad Debts | 12.15 | 12.15 | 54.87 | 21.19 | 17.09 | 15.35 |
Other Operating Activities | 64.1 | 50.44 | 37.37 | 64.18 | 76.68 | 18.66 |
Change in Accounts Receivable | 30.43 | 30.43 | -62.36 | -117.26 | -44.06 | -57.76 |
Change in Inventory | -284.74 | -284.74 | -365.94 | -37.8 | -193.28 | -113.48 |
Change in Accounts Payable | 129.16 | 129.16 | -36.95 | 18.52 | 218.9 | 324.36 |
Change in Other Net Operating Assets | -8.26 | -8.26 | 44.09 | 0.17 | 1.83 | -3.03 |
Operating Cash Flow | 1,322 | 1,342 | 1,309 | 1,470 | 1,558 | 1,461 |
Operating Cash Flow Growth | 15.23% | 2.48% | -10.92% | -5.68% | 6.65% | 46.90% |
Capital Expenditures | -590.67 | -604.3 | -664.4 | -900.42 | -938.32 | -1,066 |
Sale of Property, Plant & Equipment | 0.1 | 0.11 | 0.21 | 0.48 | 0.21 | 0.28 |
Cash Acquisitions | - | - | -1.76 | - | - | - |
Divestitures | - | - | - | -0.55 | 2.41 | - |
Investment in Securities | -12.63 | 64.92 | -564.12 | 3.33 | -165.6 | 438.1 |
Other Investing Activities | 738.07 | 123.92 | 44.85 | 109.93 | 122.65 | 116.65 |
Investing Cash Flow | 134.88 | -415.35 | -1,185 | -787.22 | -978.66 | -510.81 |
Short-Term Debt Issued | - | 1,603 | 758 | 510.08 | 796 | 736.49 |
Long-Term Debt Issued | - | 400.78 | 528.96 | 655 | 105 | 16.8 |
Total Debt Issued | 1,715 | 2,004 | 1,287 | 1,165 | 901 | 753.28 |
Short-Term Debt Repaid | - | -1,175 | -584 | -887 | -212 | -846.55 |
Long-Term Debt Repaid | - | -870.33 | -668.41 | -132.06 | -225.06 | -15.68 |
Total Debt Repaid | -1,557 | -2,045 | -1,252 | -1,019 | -437.06 | -862.24 |
Net Debt Issued (Repaid) | 157.87 | -41.16 | 34.54 | 146.02 | 463.94 | -108.95 |
Repurchase of Common Stock | -40.8 | -40.8 | -566.06 | - | -243.3 | -16.8 |
Common Dividends Paid | -723.5 | -726.68 | -623.38 | -479.12 | -438.91 | -394.81 |
Other Financing Activities | -270.76 | 12.35 | -3.93 | -3.91 | - | 18.21 |
Financing Cash Flow | -877.19 | -796.29 | -1,159 | -337.01 | -218.26 | -502.35 |
Foreign Exchange Rate Adjustments | -10.12 | 0.77 | 1.46 | 3.15 | 7.71 | -8.23 |
Net Cash Flow | 569.48 | 130.81 | -1,033 | 348.77 | 369.21 | 439.85 |
Free Cash Flow | 731.25 | 737.38 | 644.88 | 569.44 | 620.1 | 395.39 |
Free Cash Flow Growth | 28.95% | 14.34% | 13.25% | -8.17% | 56.83% | - |
Free Cash Flow Margin | 17.32% | 17.45% | 14.42% | 12.81% | 13.96% | 10.50% |
Free Cash Flow Per Share | 1.28 | 1.29 | 1.12 | 0.98 | 1.06 | 0.67 |
Cash Interest Paid | 0.93 | 0.93 | 1.25 | 0.56 | 0.67 | 0.34 |
Cash Income Tax Paid | 519.55 | 466.56 | 393.9 | 474.63 | 456.14 | 318.23 |
Levered Free Cash Flow | 1,513 | 1,245 | 492.38 | -61.09 | 834.94 | -71.38 |
Unlevered Free Cash Flow | 1,520 | 1,254 | 506.31 | -45.75 | 848.21 | -63.45 |
Change in Working Capital | -184.41 | -184.41 | -456.05 | -187.25 | -49.65 | 139.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.